Patient Compliance Executive Conference On Industry Adoption Of New Tools To Feature 25 Pharma Company Speakers, April 4-5

Main Category: Pharma Industry / Biotech Industry
Also Included In: Public Health;  Compliance
Article Date: 04 Feb 2006 - 7:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:3 stars

3 (1 votes)


Integrating Patient Compliance: Plugging the Hole in the Bucket, will bring together the largest assembly of pharmaceutical company speakers and attendees in recent memory as the Industry has begun to adopt new ways of addressing a stubborn problem that takes its toll on the country's health, the healthcare system, and Industry performance. The total societal problem of non-compliance is estimated to cost $100 billion a year, according to Strategic Research Institute.

The conference is remarkable in that new strategies and tools are finally being developed and adopted to ensure a higher rate of compliance and will be presented by an equally remarkable number of pharmaceutical companies. Speakers include executive personnel from GlaxoSmithKline, AstraZeneca, Pfizer, Merck, Berlex, Amylin, Sanofi-Aventis, Bristol-Myers Squibb, Johnson & Johnson, MedImmune, Ortho McNeil, Indevus, Daiici, Sankyo, Centocor, Genzyme, Millennium, Coley Pharma, Elan, and Wyeth.

The conference is one of six two-day tracks within the much larger "Pharmaceutical Marketing & Sales Summit," that is expected to draw between 400-600 attendees. Attendees may customize their experience session-by-session and the exceptionally large number of Pharma attendees is facilitated by the value in the options and breadth of marketing coverage. The total number of speakers for the Summit will surpass 100.

The Summit is enhanced by the shared networking breaks, nightly entertainment, and exceptional networking opportunities.

To request the agenda in pdf format, contact Seth Fritts, the organizer at sfritts@srinstitute.com or at 212.967.0095, Ext. 256.

Speaking opportunities remain and may be coordinated with sponsorship and exhibition. Exhibitors may benefit from the Pharma-intensive show by having an on site presence to attract new business.

Contact Mark Alexay at malexay@srinstitute.com or 212.967.0095, extension 251 to determine what level of exposure works best for your company. The number of Pharma client prospects is unpredented. Register now for the best space.

To learn about becoming a media partner, please email Cheryl Kahan-Radhuber at ckahan-radhuber@srinstitute.com or telephone Cheryl at 212.967.0095, Ext. 273.

Strategic Research Institute
http://www.srinstitute.com

Article adapted by Medical News Today from original press release.
Visit our pharma industry / biotech industry section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Anita Gonzales. "Patient Compliance Executive Conference On Industry Adoption Of New Tools To Feature 25 Pharma Company Speakers, April 4-5." Medical News Today. MediLexicon, Intl., 4 Feb. 2006. Web.
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/37123.php>

APA
Anita Gonzales. (2006, February 4). "Patient Compliance Executive Conference On Industry Adoption Of New Tools To Feature 25 Pharma Company Speakers, April 4-5." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/37123.php.

Please note: If no author information is provided, the source is cited instead.


Pharma Industry / Biotech Industry

Most Popular Articles



Follow Our Pharma Industry News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Pharma Industry / Biotech Industry Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »